You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 92 No. 2, AUGUST 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

RESIDUALS OF YELLOW FEVER VACCINE AFTER TEN YEARS

A Medical and Legal Problem

IRVING B. BRICK, M.D.

AMA Arch Intern Med. 1953;92(2):221-227.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IT IS MORE than 10 years since the recognition of the epidemic of homologous serum hepatitis that followed the use of yellow fever vaccine which contained, as a diluent, human serum. That many lots of this particular vaccine were icterogenic has been documented by many observers, notably Sawyer and his associates,1 Capps and his associates,2 and Hayman and Read.3 Recently, Stebbins4 has reviewed from the epidemiologic point of view the implications of this experience. While certain lots of vaccine were shown to be highly icterogenic,1 none of the donors of the serum used in these lots had experienced jaundice or hepatitis within nine months prior to the donation, although all had had jaundice sometime in the past. It appears that a chronic carrier state may develop in persons suffering from viral hepatitis and that the infectious agent may be carried in the blood in sufficient virulence to produce illness in . . . [Full Text PDF of this Article]


Author Affiliations

WASHINGTON, D. C.

From National Rehabilitation Commission, The American Legion, and Department of Medicine, Georgetown University School of Medicine.


Footnotes

This paper was presented in part at the Annual Meeting of the Association for the Study of Liver Diseases, Chicago, Nov. 1, 1952.

Dr. Brick is Assistant Professor of Medicine, Georgetown University School of Medicine, and Medical Consultant, National Rehabilitation Commission, The American Legion.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.